LB Pharmaceuticals prices USD 150 million private placement at USD 34.94 per sharePUBT·1 day ago, 07:20 AMLBRX+5.00%
Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRXrttnews·1 day ago, 03:23 AMBVS+0.69%LBRX+5.00%
LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target MaintainedTip Ranks·Jul 23 at 10:25 AMLBRX+5.00%
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRXrttnews·Jul 23 at 03:38 AMSLN-1.73%FBRX+5.00%
LB Pharmaceuticals shares are trading higher after the company announced accelerated timing for topline results from the Phase 3 NOVA-2 trial of LB-102 in Schizophrenia.benzinga_article·Jul 22 at 12:55 PMLBRX+5.00%
LB Pharmaceuticals releases update on NOVA-2 Phase 3 schizophrenia trial timelinePUBT·Jul 22 at 07:04 AMLBRX+5.00%
LB Pharmaceuticals grants SVP Zergebel option for 75,000 shares at $32.95 under Nasdaq inducement rulePUBT·Jul 10 at 03:39 PMLBRX+5.00%
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) | LBRX Stock NewsStockTitan·Jul 10 at 07:38 AMLBRX+5.00%
LB Pharmaceuticals names Christopher Zergebel SVP of clinical operationsPUBT·Jun 30 at 07:03 AMLBRX+5.00%
H.C. Wainwright Sticks to Their Buy Rating for LB Pharmaceuticals, Inc. (LBRX)Tip Ranks·Jun 8 at 12:35 PMLBRX+5.00%
